Financial Markets | ||||||
NEWS | ||||||
Global shares start busy data week solidly Global stock markets advanced Monday ahead of a raft of potentially market-moving economic data from around the world that culminates with U.S. jobs data for April. KEEPING SCORE: In Europe, Germany's DAX was up 0.1 percent to 12,591 while the CAC 40 of France rose 0.4 percent to 5,499.
| ||||||
OTC Markets Group Welcomes First Cobalt Corp to OTCQX NEW YORK, April 30, 2018 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced First Cobalt Corp (TSX-V: FCC; ASX: FCC; OTCQX: FTSSF), a cobalt exploration and development company, has qualified to trade ...
| ||||||
Update on the latest in business: FINANCIAL MARKETS. Shares higher in Asia, some markets closed for holidays. UNDATED (AP) — Shares were higher in Hong Kong, Australia and South Korea on Monday following the release of reassuring manufacturing data for China, though a number of Asian markets are closed for holidays.
| ||||||
Hearing examines SEC investor protection, capital formation efforts "Our shared goal should be to reverse the negative trend of declining IPO's and focus on capital formation. Hardworking families across the nation rely on the capital markets to save for everything from college to retirement. By making capital formation the priority, we can maximize Mr. and Mrs. 401(k)'s ...
| ||||||
Still humming, strong economy puts popular credit-risk investing strategies ... at risk Aaron Kohli, a financial strategist with BMO Capital Markets, sees signs that the end of the economic cycle is already close at hand. One of the clearest is pressure on corporate margins, which bodes ill for corporate earnings down the road. "Inflation has been less responsive to wage gains than in the ...
| ||||||
Alder BioPharmaceuticals® to Host Conference Call to Discuss First Quarter 2018 Financial and ... ... Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today announced that it will report its first quarter 2018 financial and operating results after the close of U.S. financial markets on Tuesday, ...
| ||||||
See more results | Edit this alert |
You have received this email because you have subscribed to Google Alerts. |
Receive this alert as RSS feed |
Send Feedback |
No comments:
Post a Comment